PhD Scientific Days 2026

Pharmaceutical Sciences and Health Technologies 1.

Cardiovascular Safety of Vista Immune Checkpoint Inhibition: Evidence from Human Heart Failure and Murine Models

Name of the presenter

Jakab, Márk

Institute/workplace of the presenter

Departement of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary

Authors

Márk Jakab^1,2, Zsombor I. Hegedűs^1,2,3, Tamás Gergely^1,2,3, Péter Ferdinandy^1,3,4, Zoltán V. Varga^1,2,3

1: Center for Pharmacology and Drug Research and Development, Semmelweis University, Budapest, Hungary
2: MTA-SE Momentum Cardio-Oncology and Cardio-Immunology Research Group, Budapest, Hungary
3: Departement of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary
4: Pharmahungary Group, Szeged, Hungary